Aurobindo Pharma Ltd (AUROPHARMA) — Announcement | 29 September 2026

29 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

GST appellate order confirms reversal of Rs. 2.56 crore excess ITC claim

🔄 What Changed

Order confirmed reversal of alleged excess ITC claim

💡 Investor Takeaway

Routine procedural filing with no direct impact on shareholders.

Aurobindo Pharma disclosed a GST appellate order confirming reversal of Rs. 2.56 crore excess input tax credit claim for FY 2020-21, including Rs. 1.78 crore interest and Rs. 25.65 lakh penalty, though the company states there is no material impact on financials or operations.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AUROPHARMA ✨ Ask AI About This

About Aurobindo Pharma Ltd (AUROPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹97,814.24 CrP/E: 26.6ROE: 9.8%ROCE: 12.8%Div Yield: 0.24%

View full AUROPHARMA stock details →

📡 Get AI alerts when AUROPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AUROPHARMA — Free

💡 Ask AI about this filing

"What is the status of the GST appeal before the tribunal?""How does this affect Aurobindo's future tax filings?""What is the peer comparison for GST liabilities in pharma?"

Ask AI Free →

📊 More AUROPHARMA filings

Announcement — 24 September 2026Aurobindo Pharma announced that its trading window will close on October 1, 2026, for all designated...
🔴 Announcement — 21 September 2026Aurobindo Pharma announced its participation in a JP Morgan Healthcare Trip investor meeting in Hyde...
🔴 Announcement — 15 September 2026Aurobindo Pharma announced USFDA final approval for its first metered-dose inhaler, Beclomethasone D...
🔴 Announcement — 15 September 2026Aurobindo Pharma announced the completion of a US FDA inspection at its Apitoria Pharma subsidiary's...
🔴 Corporate Action — 12 September 2026Aurobindo Pharma announced its step-down subsidiary A1 Biochem Labs (India) acquired 100% of newly i...

See all AUROPHARMA filings →

🔥 Also filed on 29 September 2026

ADANIPOWERAdani Power LtdAnnouncement APOLLOApollo Micro Systems LtdAnnouncement ADANIENTAdani Enterprises LtdAnnouncement ADANIPORTSAdani Ports & Special Economic Zone LtdAnnouncement PFOCUSPrime Focus LtdAnnouncement MCXMulti Commodity Exchange of India LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AUROPHARMA files new disclosures

Track AUROPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.